The genetic contribution to coronary heart disease through lipoprotein concentrations
Slack, J.
Postgraduate Medical Journal 51(8): 27-32
1975
ISSN/ISBN: 0032-5473 PMID: 1221377 Document Number: 89573
Document emailed within 1 workday
Related Documents
Khan, M.A.; Baseer, A. 2000: Lipoprotein(a) status in coronary heart disease Jpma. Journal of the Pakistan Medical Association 50(2): 47-50Duriez, P.; Dallongeville, J.; Fruchart, J.C. 1994: Lipoprotein(a) as a marker for coronary heart disease British Journal of Clinical Practice. Suppl 77: 51-58
Vashisht, S.; Wasir, H.; Srivastava, L.M. 1992: Association between incidence of lipoprotein(a) positivity and coronary heart disease Indian Heart Journal 44(4): 223-226
Tunstall Pedoe, H.; Kuulasmaa, K.; Mahonen, M.; Tolonen, H.; Ruokokoski, E.; Amouyel, P. 1999: Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-Year results from 37 WHO MONICA Project populations Lancet (North American Edition) 353(9164): 1547-1557
Su, Z.; Zhang, S.; Hou, Y.; Zhang, L.; Liao, L.; Xiao, C. 2002: Relationship between a novel polymorphism of lipoprotein lipase gene and coronary heart disease Chinese Medical Journal 115(5): 677-680
Futterman, L.G.; Lemberg, L. 2001: Lp(a) lipoprotein--an independent risk factor for coronary heart disease after menopause American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 10(1): 63-67
Stober, C.; Clarke, A.; Mulvaney, A.; Harland, J.; Neithercut, W.D. 1994: Cholesterol and lipoprotein(a) as risk factors for coronary heart disease in elderly subjects British Journal of Biomedical Science 51(2): 114-118
Nogués, X.; Sentí, M.; Pedro-Botet, J.; Molina, L.; Serrat, R.; Pons, S.; Rubiés-Prat, J. 1992: Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors Medicina Clinica 98(5): 171-174
Ragoobirsingh, D. 1989: The relationship between different lipoprotein fractions and the incidence of coronary heart disease in diabetics of Trinidad and Tobago West Indian Medical Journal 38(1): 42-47
Adebonojo, S.A.; Ogunnaike, H.O. 1989: High density lipoprotein cholesterol as a determinant factor in coronary heart disease in Africans Journal of the National Medical Association 81(5): 547-556
Kalinina, A.M.; Chazova, L.V.; Perova, N.V.; Pavlova, L.I.; Shchepkin, V.V. 1993: An increased risk of death from ischemic heart disease in men with low blood concentrations of total cholesterol and low-density lipoprotein cholesterol Terapevticheskii Arkhiv 65(4): 27-32
Srinivasan, S.R.; Berenson, G.S. 1995: Childhood lipoprotein profiles and implications for adult coronary artery disease: the Bogalusa Heart Study American Journal of the Medical Sciences 310(Suppl): S62-S67
Guţiu, I.A.; Galeţescu, E.; Guţiu, L.I.; Răducu, L. 1996: Diagonal earlobe crease: a coronary risk factor, a genetic marker of coronary heart disease, or a mere wrinkle. Ancient Greco-Roman evidence Romanian Journal of Internal Medicine 34(3-4): 271-278
Kassem, N.S.; Mokhtar, M.M.; Elbel-Bessy, M.F. 1994: Genetic markers in coronary heart disease Journal of the Egyptian Public Health Association 69(5-6): 359-378
Meurice, C.; Legrand, V.; Piérard, L. 2016: Contribution of Cardiac Catheterization to the Diagnosis and Treatment of Coronary Heart Disease before Age 40 Revue Medicale de Liege 71(3): 129-136
Li, Z.X. 1982: Serum high density lipoprotein cholesterol (HDL-C) level and its regulating factors in healthy subjects and patients with coronary heart disease Zhonghua Yi Xue Za Zhi 62(1): 13-17
Holtzman, E.; Rosenthal, T.; Goldbourt, U.; Segal, P. 1984: Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status Israel Journal of Medical Sciences 20(12): 1169-1176
Athyros, V.G.; Mikhailidis, D.P.; Papageorgiou, A.A.; Mercouris, B.R.; Athyrou, V.V.; Symeonidis, A.N.; Basayannis, E.O.; Demitriadis, D.S.; Kontopoulos, A.G. 2002: Attaining United Kingdom-European Atherosclerosis Society low-density lipoprotein cholesterol guideline target values in the Greek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study Current medical research and opinion 18(8): 499-502
Staunton, A.; Vallance, D.T.; Child, A.; Camm, A.J.; Winder, A.F. 1994: Unrecognized dyslipoproteinemia in United Kingdom families recruited to a genetic register because of unexplained coronary heart disease Journal of Laboratory and Clinical Medicine 123(6): 842-848
Weber, M.; McNicoll, S.; Marcil, M.; Connelly, P.; Lussier-Cacan, S.; Davignon, J.; Latour, Y.; Genest, J. 1997: Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians Canadian Journal of Cardiology 13(3): 253-260